These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 7673432

  • 1. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.
    Villadolid MC, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K, Kiriyama T, Uetani M, Nagataki S.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432
    [Abstract] [Full Text] [Related]

  • 2. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
    Kvetny J, Puhakka KB, Røhl L.
    Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
    [Abstract] [Full Text] [Related]

  • 3. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K, De Bellis A, Li AW, Yamada M, Kubota S, Ackrell B, Wengrowicz S, Bellastella A, Bizzarro A, Sinisi A, Wall JR.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [Abstract] [Full Text] [Related]

  • 4. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Acta Med Hung; 1991 Apr; 48(1-2):13-21. PubMed ID: 1813853
    [Abstract] [Full Text] [Related]

  • 5. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.
    Yokoyama N, Nagataki S, Uetani M, Ashizawa K, Eguchi K.
    Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043
    [Abstract] [Full Text] [Related]

  • 6. The relationship between anti-human eye muscle antibodies and thyroid function, anti-TSH receptor antibodies and eye symptoms in Graves' ophthalmopathy.
    Molnár I, Balázs C.
    Wien Klin Wochenschr; 1992 Mar; 104(24):744-7. PubMed ID: 1363165
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K, De Bellis A, Kubota S, Swanson J, Wengrowicz S, Cochran B, Ackrell BA, Salvi M, Bellastella A, Bizzarro A, Sinisi AA, Wall JR.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Graves' disease of the orbit.
    Weber AL, Dallow RL, Sabates NR.
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [Abstract] [Full Text] [Related]

  • 11. [The role of antibodies in Graves' ophthalmopathy].
    Molnár I, Balázs C.
    Orv Hetil; 1991 Sep 22; 132(38):2097-100. PubMed ID: 1923482
    [Abstract] [Full Text] [Related]

  • 12. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW, Hiromatsu Y, Laryea E, Wosu L, How J, Wall JR.
    J Clin Endocrinol Metab; 1986 Aug 22; 63(2):316-22. PubMed ID: 3755139
    [Abstract] [Full Text] [Related]

  • 13. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
    Nishikawa M, Yoshimura M, Toyoda N, Masaki H, Yonemoto T, Gondou A, Kato T, Kurokawa H, Furumura T, Inada M.
    Acta Endocrinol (Copenh); 1993 Sep 22; 129(3):213-9. PubMed ID: 8105634
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F, Zamboni G, Cerini R, Lauriola S, Dall'Agnola A, Tatò L.
    J Pediatr; 2004 Apr 22; 144(4):527-31. PubMed ID: 15069405
    [Abstract] [Full Text] [Related]

  • 19. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.
    Zhu H, Zou M, Wu D, Li B, Su Y, Li Y, Hong S, Yang Z.
    Eur Radiol; 2023 Dec 22; 33(12):9074-9083. PubMed ID: 37466707
    [Abstract] [Full Text] [Related]

  • 20. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy.
    Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall JR.
    J Clin Endocrinol Metab; 1988 Sep 22; 67(3):565-70. PubMed ID: 3410941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.